Delivery Order SPE2DR25D7068-SPE2DR26F5BS2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5ml) with a ceiling value of $1,645.80. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025. AmerisourceBergen will perform the work from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.80 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on November 20, 2025, with completion expected by November 21, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a delivery order valued at $13,961.35 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract employs firm fixed price pricing and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,490.08 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on December 1, 2025, with an ultimate completion date of December 2, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a $1,625.90 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of July 30, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,606.36 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on December 5, 2025, with a completion date of December 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BS2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.80 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed-price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025. This is a competitively awarded, non-set-aside delivery order executed out of AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply requirements across multiple therapeutic domains, from specialty medications to generic pharmaceuticals and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/25/25 |